Kane Biotech (TSE:KNE) has released an update.
Kane Biotech Inc. has announced an extension of the exclusivity period for its offer in STEM Animal Health until March 31, 2024, following an initial offer made in December 2023. The company has also secured an additional US $900,000 in deposits towards the sale of its interest in STEM, on top of the US $625,000 received at the time of the offer. Kane Biotech specializes in the development of products that combat microbial biofilms and holds a robust portfolio of biotechnologies and intellectual property.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.
